BioCatalystWatch
PCVXWorkspace / PCVX / OverviewCompany library
Price
Market cap
Next catalystExpected 2026VAX-31 · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-A1

Streptolysin O (SLO) × C5a peptidase (ScpA) × SpyAD × Modified Group A carbohydrate (GACPR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-A1

Streptolysin O (SLO) × C5a peptidase (ScpA) × SpyAD × Modified Group A carbohydrate (GACPR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

VAX-31

31 pneumococcal serotypes × Pneumococcal serotype 20C

PreINDP1P2P3FilingApproved
Upcoming / outlook

VAX-24

24 pneumococcal capsular serotypes

PreINDP1P2P3FilingApproved
VAX-XL

Pneumococcal serotypes

PreINDP1P2P3FilingApproved

History / paused

VAX-24

24 pneumococcal capsular serotypes

PreINDP1P2P3FilingApproved

IpaB × IpaH × VirG × Shigella LPS

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PCVX SEC archive